In August 2021 Finfeed changed from a website that covered ASX listed news to a website
that covered a select range of ASX
listed small cap Biotech stocks that we are personally invested in: find out more.
The old Finfeed website, and all of the old articles are kept here for record keeping purposes.VISIT NEW SITE
What’s the upside for 88 Energy?
1 minute read
Hartleys analyst, Aiden Bradley has run the ruler across 88 Energy (ASX | AIM: 88E) as the company progresses with its drilling campaign which is expected to see it positioned to undertake production testing at the Icewine#2 oil reservoir located on the North Slope of Alaska in June/July.
Bradley noted that based on the results of the Icewine#1 well, situated just 20 metres away, expectations are that this well will flow oil to surface in a range between 100 barrels of oil per day and 200 barrels of oil per day.
While Bradley noted that one well does not prove a ‘Play’, he anticipates success would likely be sufficient to attract a major farm-in partner which would support the current valuation.
Despite recent weakness in the oil price, 88E has traded strongly in the last two months with its share price increasing more than 30% from 3.8 cents to an intraday high of 5 cents on Monday.
However, this is well shy of Bradley’s valuation of 7 cents, implying upside of 40% to yesterday’s high, and he has a speculative buy recommendation on the stock.
While acknowledging the benefits of success in the unconventional Icewine project, he believes the share price doesn’t capture the value of its 15 conventional leads and a potential resource of over 1 billion barrels net as outlined below under ‘conventional leads’.
It should be noted here that broker projections and price targets are only estimates and may not be met. Also, share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.